nimodipine capsule, liquid filled
mckesson corporation dba sky packaging - nimodipine (unii: 57wa9qz5wh) (nimodipine - unii:57wa9qz5wh) - nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., hunt and hess grades i-v). the concomitant use of nimodipine with strong inhibitors of cyp3a4 such as some macrolide antibiotics (e.g., clarithromycin, telithromycin), some anti-hiv protease inhibitors (e.g., delaviridine, indinavir, nelfinavir, ritonavir, saquinavir), some azole antimycotics (e.g., ketoconazole, itraconazole, voriconazole) and some antidepressants (e.g., nefazadone) is contraindicated because of a risk of significant hypotension (see precautions, drug interactions ). there have been no reported instances of drug abuse or dependence with nimodipine capsules.
nimodipine capsules for oral use rx only
heritage pharmaceuticals inc. - nimodipine (unii: 57wa9qz5wh) (nimodipine - unii:57wa9qz5wh) - nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., hunt and hess grades i-v). the concomitant use of nimodipine with strong inhibitors of cyp3a4 such as some macrolide antibiotics (e.g., clarithromycin, telithromycin), some anti-hiv protease inhibitors (e.g., delaviridine, indinavir, nelfinavir, ritonavir, saquinavir), some azole antimycotics (e.g., ketoconazole, itraconazole, voriconazole) and some antidepressants (e.g., nefazadone) is contraindicated because of a risk of significant hypotension (see precautions, drug interactions) there have been no reported instances of drug abuse or dependence with nimodipine
nymalize- nimodipine solution
arbor pharmaceuticals - nimodipine (unii: 57wa9qz5wh) (nimodipine - unii:57wa9qz5wh) - nimodipine 60 mg in 20 ml - nymalize is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (sah) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., hunt and hess grades i-v). none. risk summary there are no adequate data on the developmental risk associated with the use of nymalize in pregnant women. in animal studies, oral administration of nimodipine during pregnancy resulted in adverse effects on development (increased embryofetal mortality, increased incidences of fetal structural abnormalities, decreased fetal growth) at doses equivalent to (rat) or less than (rabbit) those used clinically [see data] . in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 2-4% and 15-20% respectively. the background risk of major birth defects and miscarriage for the indicated population is unknow
nymalize- nimodipine solution
azurity pharmaceuticals, inc. - nimodipine (unii: 57wa9qz5wh) (nimodipine - unii:57wa9qz5wh) - nymalize is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (sah) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., hunt and hess grades i-v). none. risk summary there are no adequate data on the developmental risk associated with the use of nymalize in pregnant women. in animal studies, oral administration of nimodipine during pregnancy resulted in adverse effects on development (increased embryofetal mortality, increased incidences of fetal structural abnormalities, decreased fetal growth) at doses equivalent to (rat) or less than (rabbit) those used clinically [see data] . in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. the background risk of major birth defects and miscarriage for the indicated population is unknown. d
nimodipine hexal® 30 mg film-coated tablet
imeks pharma sdn. bhd. - nimodipine -
nimodipine carinopharm 10 mg/50 ml infusion solution
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - nimodipine - solution for infusion - nimodipine 10/50 mg/ml - calcium channel blockers
nimodipine labesfal 30mg coated tablets
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - nimodipine - coated tablet - nimodipine 30 mg - calcium channel blockers
nimotop nimodipine 30 mg tablets blister pack
bayer australia ltd - nimodipine, quantity: 30 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; maize starch; crospovidone; magnesium stearate; hypromellose; macrogol 4000; iron oxide yellow; titanium dioxide - prophylaxis and treatment of ischaemic neurological deficits caused by cerebral vasospasm after subarachnoid haemorrhage following ruptured intracranial aneurysm, in patients who are in good neurological condition post-ictus (eg hunt and hess grades i-iii).
nimotop 0.02% solution for infusion
bayer plc - nimodipine - solution for infusion or injection - nimodipine 0.02 % (w/v) - calcium channel blockers
nimotop 0.02% w/v concentrate for solution for infusion
bayer limited 1st floor the grange offices the grange brewery road stillorgan co. dublin, a94 h2k7 , ireland - nimodipine - concentrate for solution for infusion - nimodipine 0.2 mg/ml - calcium channel blockers